DRUGS related term(s) Crime

Amendments

Dept. of Justice: provide with additional tools to target extraterritorial drug trafficking activity (S. 1612), S8689, S8690 [15DE]

Appointments

Senate Caucus on International Narcotics Control, S3000 [16MY]

Articles and editorials

Absolute Scandal, S6986 [1NO]

Dodging Bullets in El Paso, H236 [18JA]

Falling Crime, Teeming Prisons, S6984 [1NO]

Justice System Needs To Be Studied, S6985 [1NO]

Republicans Block Justice Review Proposal in Senate, S6985 [1NO]

Senate Negligence on Crime Reform, S6986 [1NO]

Shaky Arguments Block Federal Commission on Crime, S6985 [1NO]

Tapp Wins Prestigious Judicial Award, S6658 [18OC]

U.S. Border Agent Jailed for Improper Arrest of Suspected Drug Smuggler, H7115 [26OC]

Ultralight Aircraft Now Ferrying Drugs Across U.S.-Mexico Border, S5260 [2AU]

Bills and resolutions

Agriculture: prohibit open-air cultivation or use of human food or animal feed as host plant and establish tracking system to regulate genetically engineered pharmaceutical and industrial crops (see H.R. 3554), H8124 [2DE]

Aviation: include ultralight aircraft under the definition of aircraft relative to aviation smuggling and identify equipment and technology to track illegal use of such aircraft near the Mexican border (see S. 1485), S5250 [2AU] (see S. 1974), S8461 [8DE]

Centers for Disease Control and Prevention: establish and implement a birth defects prevention, risk reduction, and public awareness program (see S. 1131), S3427 [26MY] (see H.R. 2029), H3755 [26MY]

Civil liberties: protect first amendment rights of individuals to share their experiences and perceptions of the effects of foods and dietary supplements (see H.R. 2908), H6139 [13SE]

Cocaine: apply reduced sentences for certain cocaine based offenses retroactively for certain offenders (see H.R. 2316), H4526 [23JN]

Colombia: support citizens in aftermath of flooding, renew Andean Trade Promotion and Drug Eradication Act extension, promote economic growth, and reinforce fight against drug trafficking (see H. Res. 77), H551 [8FE]

Contraceptives: establish certain duties for pharmacies to ensure provision of FDA-approved contraception (see S. 1415), S4911 [26JY] (see H.R. 2659), H5579 [26JY]

Controlled Substances Act: authorize practitioners other than physicians to dispense certain narcotic drugs for maintenance or detoxification treatment without obtaining separate registration (see H.R. 1729), H3060 [4MY]

———exclude industrial hemp from the definition of marijuana (see H.R. 1831), H3217 [11MY]

———place synthetic drugs in Schedule I indicating high potential for abuse, no current accepted medical use, and lack of accepted safety for use under medical supervision (see S. 605), S1826 [17MR] (see H.R. 1254), H2106 [30MR]

Correctional institutions: provide for an effective HIV/AIDS program in Federal prisons (see H.R. 3547), H8075 [1DE]

Courts: clarify circumstances under which the enhanced penalty provisions for subsequent convictions apply (see H.R. 2398), H4575 [24JN]

———provide for deferred sentencing and the possibility of dismissal for drug offenders (see H.R. 2567), H5125 [15JY]

Crime: address sentencing disparity between crack and powder cocaine (see H.R. 2242), H4332 [20JN]

———clarify that persons who conspire or engage in conduct within the U.S. to possess, traffic, or abet traffickers of illegal drugs outside the U.S., may be criminally prosecuted in the U.S. (see S. 1672), S6330 [6OC] (see H.R. 313), H254 [18JA]

———concentrate Federal resources aimed at the prosecution of drug offenses on major offenses (see H.R. 2303), H4457 [22JN]

———deploy Border Patrol agents and increase number of DEA and ATF agents along U.S. border to identify and eliminate illicit sources of firearms smuggled into Mexico for use by drug traffickers (see H.R. 77), H35 [5JA]

———enhance penalties for marketing controlled substances to minors (see S. 513), S1406 [8MR]

———increase penalties for counterfeit drug trafficking (see S. 1886), S7702 [17NO] (see H.R. 3468), H7829 [17NO] (see H.R. 3668), H8966 [14DE]

———increase penalties for operators of pill mills (see S. 1760), S6872 [20OC] (see H.R. 1065), H1796 [14MR]

———increase penalties for stealing, transporting, and storing stolen prescription drugs (see S. 1002), S2992 [16MY]

———subject vehicles, other conveyances, and instruments of international traffic to seizure and forfeiture for smuggling (see H.R. 3033), H6413 [22SE]

Cuba: facilitate export of U.S. agricultural products, remove impediments to export of medical devices and medicines, allow travel by U.S. citizens, and establish an agricultural export promotion program (see H.R. 1888), H3279 [12MY]

DEA: authorize certain health care professionals in nursing homes to transmit DEA-licensed practitioners' orders to deliver pain medications (see S. 1560), S5624 [14SE]

Dept. of Defense: authorize a pilot program on enhancements of efforts on mental health in the National Guard and Reserves through community partnerships (see S. 1465), S5192 [1AU] (see H.R. 2751), H5884 [1AU]

———provide funds to States for use of the National Guard, State defense forces, and law enforcement agencies in securing an international border that forms part of a State border (see H.R. 2025), H3754 [26MY]

Dept. of Education: authorize grant programs to ensure successful, safe, and healthy students by promoting wellness, preventing bullying, violence, and drug use, and fostering a positive school climate (see S. 919), S2777 [9MY]

Dept. of HHS: amend and reauthorize the controlled substance monitoring program (see H.R. 866), H1455 [1MR]

———establish an America Rx drug discount program for individuals without access to prescription drugs at discounted prices (see H.R. 2296), H4456 [22JN]

———provide States with incentives to require elementary and secondary schools to maintain, and permit school personnel to administer, epinephrine (see S. 1884), S7702 [17NO] (see H.R. 3627), H8318 [8DE]

———reauthorize grants to assist children affected by methamphetamine or other substance abuse under the Promoting Safe and Stable Families program (see S. 1234), S3924 [20JN]

———revise and expand the 340B Drug Pricing Program to improve provision of discounts on drug purchases for certain safety net providers (see H.R. 2674), H5660 [27JY]

———revise minimum allotments under the Projects for Assistance in Transition From Homelessness (PATH) Program (see H.R. 3141), H6672 [6OC]

Dept. of Homeland Security: implement a comprehensive border security plan to combat illegal immigration, drug and alien smuggling, and violent activity along the southwest border of the U.S. (see S. 803), S2446 [13AP] (see H.R. 1507), H2664 [13AP]

———provide U.S. Customs and Border Protection with access to Federal lands to carry out certain security activities in the Southwest border region (see H.R. 1922), H3301 [13MY]

———reduce trafficking of drugs and prevent human smuggling across the Southwest border by deterring construction and use of border tunnels (see S. 1236), S3924 [20JN] (see H.R. 2264), H4364 [21JN]

Dept. of HUD: reauthorize the Public Housing Drug Elimination Program (see H.R. 378), H395 [20JA]

Dept. of Justice: close the National Drug Intelligence Center (see H.R. 566), H598 [9FE]

———establish the Alaska Safe Families and Villages Demonstration Project (see S. 1192), S3773 [14JN]

———establish the National Parents Corps Program (see H.R. 3055), H6455 [23SE]

———provide with additional tools to target extraterritorial drug trafficking activity (see S. 1612), S5903 [22SE]

Dept. of State: designate as foreign terrorist organizations certain Mexican drug cartels (see H.R. 1270), H2106 [30MR]

Dept. of Transportation: establish and maintain national clearinghouse for alcohol and controlled substances testing records of commercial motor vehicle operators (see S. 754), S2266 [7AP] (see H.R. 2459), H4792 [8JY]

———establish grant program to improve traffic safety of teen drivers (see S. 1422), S4960 [27JY]

Dept. of Veterans Affairs: provide for certain requirements relative to immunization of veterans (see S. 1799), S7127 [3NO] (see H.R. 1930), H3302 [13MY]

Diseases: commend progress made by anti-tuberculosis programs (see H. Res. 176), H1985 [17MR]

———de-link research and development incentives from drug prices for new medicines to treat HIV/AIDS and stimulate greater sharing of scientific knowledge (see S. 1138), S3428 [26MY]

———reduce disparities and improve access to diagnosis and treatment of prostate cancer for underserved populations and men with a family history of prostate cancer (see S. 1190), S3773 [14JN] (see H.R. 2159), H4185 [14JN]

———require group and individual health insurance coverage and group health plans to cover oral cancer drugs on terms no less favorable than coverage provided for intravenously administered anticancer medications (see H.R. 2746), H5883 [1AU]

Drug testing: prohibit the manufacture, marketing, sale, or shipment of products designed to assist in defrauding a drug test (see H.R. 707), H922 [15FE]

EPA: convene a task force to develop recommendations on the proper disposal of unused pharmaceuticals (see H.R. 1677), H2933 [2MY]

FDA: allow fast track approval of certain orphan drugs (see H.R. 3737), H10013 [20DE]

———allow manufacturers to distribute and cite scientific research on health benefits of foods and dietary supplements without affecting regulatory category of the product (see H.R. 1364), H2326 [5AP]

———ensure valid generic drugs may enter the market (see S. 1882), S7612 [16NO]

———establish a nanotechnology regulatory science program (see S. 1662), S6330 [6OC]

———improve capacity to prevent drug shortages (see S. 296), S614 [7FE] (see H.R. 2245), H4363 [21JN]

———improve priority review voucher incentive program for expedited review of treatments for tropical and rare pediatric diseases (see S. 606), S1826 [17MR] (see H.R. 3059), H6456 [23SE]

———improve the safety of Internet pharmacies (see S. 2002), S8679 [15DE]

———modify approval of any drug containing controlled-release oxycodone hydrochloride to limit such approval to use for relief of severe-only pain (see H.R. 1316), H2265 [1AP]

———provide additional quality control of drugs (see S. 1584), S5773 [20SE]

———provide for regulation of medical gases (see H.R. 2227), H4326 [16JN]

———provide incentives for the development of qualified infectious disease products (see S. 1734), S6764 [19OC] (see H.R. 2182), H4276 [15JN]

Federal employees: ensure Federal Employees Health Benefit Program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits (see H.R. 979), H1664 [9MR]

Federal Food, Drug, and Cosmetic Act: ensure accurate, intelligible information on dosage delivery devices packaged with liquid over-the-counter medications (see H.R. 338), H354 [19JA]

Government regulations: ban the sale of certain synthetic drugs (see S. 409), S871 [17FE] (see S. 839), S2506 [14AP] (see H.R. 1571), H2909 [15AP]

———increase Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths (see S. 507), S1406 [8MR] (see H.R. 1925), H3302 [13MY]

Health: apply antitrust laws to negotiations between groups of independent pharmacies and health plans and health insurance issuers in the same manner as collective bargaining by labor organizations (see H.R. 1839), H3218 [11MY]

———extend health information technology assistance eligibility to behavioral health, mental health, and substance abuse professionals and facilities (see S. 539), S1546 [10MR]

———permit an individual to be treated by a health care practitioner with any method of medical treatment such individual requests (see H.R. 2736), H5883 [1AU]

———provide coverage of hormone replacement therapy and alternative therapies for treatment of menopausal symptoms (see H.R. 383), H395 [20JA]

———raise awareness of the risk of internal bleeding for patients taking anti-coagulant drugs (see H. Res. 279), H3645 (see H. Res. 279), H3683 [25MY]

———support regenerative medicine through research funding and commercial development and develop a regulatory environment that enables rapid approval of safe and effective products (see H.R. 1862), H3278 [12MY]

Health care professionals: authorize physicians to transport controlled substances from a practice setting to another practice setting or to a disaster area (see H.R. 3724), H9926 [16DE]

———require practitioners to obtain particular training or special certification on addiction and substance abuse, and appropriate and safe use of certain controlled substances (see H.R. 2119), H4034 [3JN]

———support establishment of Doctor of Nursing Practice and Doctor of Pharmacy dual degree programs (see S. 53), S123 [25JA]

Hereditary Angioedema Awareness Day: observance (see S. Res. 286), S6185 [5OC]

Holder, Attorney General: express no confidence due to lack of monitoring and actions during investigation into whistleblower allegations relative to operations transferring firearms to drug cartels (see H. Res. 490), H8727 [12DE]

Insurance: ensure transparency and proper operation of pharmacy benefit managers (see S. 1058), S3275 [24MY] (see H.R. 1971), H3409 [24MY]

Law enforcement: coordinate efforts to protect U.S. border cities from drug trafficking, gunrunning, illegal alien smuggling, violence, and kidnapping along and across U.S. borders (see H.R. 770), H1176 (see H.R. 770), H1196 [17FE] (see H.R. 915), H1574 [3MR]

———improve detection of the fraudulent abuse of prescriptions to obtain controlled substances in schedule II or III (see H.R. 1266), H2106 [30MR]

———increase evidentiary standard required to convict a person for a drug offense and require screening of law enforcement officers or others acting under color of law participating in drug task forces (see H.R. 231), H134 [7JA]

———limit application of Federal laws to the distribution and consumption of marijuana (see H.R. 2306), H4526 [23JN]

Marijuana: reschedule under the Controlled Substances Act and allow for medicinal use in accordance with State laws (see H.R. 1983), H3644 (see H.R. 1983), H3682 [25MY]

Medicaid: encourage States to increase generic drug utilization (see S. 1356), S4554 [13JY] (see H.R. 3342), H7330 [3NO]

———remove exclusion from medical assistance of items and services for patients in mental institutions (see H.R. 340), H354 [19JA]

———require drug manufacturers to pay rebates to State prescription drug discount programs as a condition of participation in a rebate agreement for outpatient prescription drugs (see H.R. 989), H1665 [9MR]

Medicare: apply exceptions process fairly for tiered formulary drugs in prescription drug plans (see H.R. 3613), H8318 [8DE]

———authorize the Dept. of HHS to negotiate lower covered part D prescription drug prices for beneficiaries (see S. 31), S122 [25JA]

———cover supplies associated with insulin injection, home needle removal, decontamination, and disposal devices, and disposal of needles and syringes through a sharps-by-mail or similar program (see S. 725), S2130 [5AP] (see H.R. 3150), H6781 [11OC]

———deliver a meaningful drug benefit and lower prescription drug prices (see S. 560), S1547 [10MR] (see H.R. 999), H1723 [10MR]

———exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals (see S. 733), S2130 [5AP] (see H.R. 905), H1573 [3MR]

———expand access to medication therapy management services (see S. 274), S543 [3FE]

———extended coverage of immunosuppressive drugs for kidney transplant patients and other renal dialysis provisions (see S. 1454), S5071 [29JY] (see H.R. 2969), H6271 [20SE]

———improve access to physical medicine and rehabilitation services (see H.R. 2785), H5885 [1AU]

———permit coverage of certain covered part D drugs for uses that are determined to be for medically accepted indications based upon clinical evidence in peer reviewed medical literature (see H.R. 1055), H1769 [11MR]

———prevent fraud and abuse and require National Provider Identifiers for reimbursement of prescriptions under part D (see H.R. 3474), H7889 [18NO]

———prevent payment adjustments for professionals who are not successful electronic prescribers and remove electronic prescribing as element for use of certified electronic health record (EHR) technology (see H.R. 2128), H4035 [3JN]

———promote medication therapy management under the part D prescription drug program (see H.R. 891), H1573 [3MR]

———provide coverage for the shingles vaccine (see H.R. 859), H1454 [1MR]

———provide for coverage of home infusion drug therapy (see S. 1203), S3813 [15JN] (see H.R. 2195), H4277 [15JN]

———reduce the costs of prescription drugs (see S. 1699), S6461 [12OC]

———require drug manufacturers to provide rebates for drugs dispensed to low-income individuals under the prescription drug benefit program (see S. 1206), S3813 [15JN] (see H.R. 2190), H4277 [15JN]

———require the Dept. of HHS to negotiate lower covered part D prescription drug prices for beneficiaries (see S. 44), S123 [25JA] (see H.R. 2248), H4363 [21JN]

———study issues on access to intravenous immune globulin (IVIG) for beneficiaries in all care settings and establish demonstration project on benefits of coverage to administer IVIG in the home (see S. 960), S2928 [12MY] (see H.R. 1845), H3218 [11MY]

Medicare/Medicaid: prevent misuse, overutilization, and trafficking of prescription drugs by limiting access to such drugs by high-risk beneficiaries (see S. 882), S2686 [4MY]

Mexico: apply counterinsurgency tactics under a coordinated and targeted strategy to combat terrorist insurgency waged by transnational criminal organizations (see H.R. 3401), H7405 [10NO]

Motor vehicles: exempt certain farm vehicles from certain operating requirements (see H.R. 2414), H4671 [6JY]

National Criminal Justice Commission: establish (see S. 306), S629 [8FE]

National Medicine Abuse Awareness Month: designate (see S. Res. 261), S5536 [13SE]

National security: deploy National Guard to assist U.S.-Mexico border control activities (see H.R. 152), H39 [5JA]

———improve border security (see H.R. 1299), H2214 [31MR] (see H.R. 1921), H3301 [13MY]

———recognize importance of biosecurity and agrodefense (see S. Res. 47), S642 [10FE]

———strengthen (see S. 8), S122 [25JA]

Office of National Drug Control Policy: develop a Federal Lands Counterdrug Strategy (see H.R. 759), H1176 (see H.R. 759), H1195 [17FE]

Omnibus Crime Control and Safe Streets Act: reauthorize and amend relative to drug courts (see H.R. 82), H35 [5JA]

Patient Protection and Affordable Care Act: repeal limits on distributions from tax-preferred accounts for certain medicines and tax increase on certain distributions from health and medical savings accounts (see H.R. 524), H549 [8FE]

———repeal limits on health-related tax benefits and treat high deductible plans as qualified health plans (see H.R. 450), H506 [26JA]

———repeal prohibition on using medical savings account funds to purchase over-the-counter medications (see S. 1368), S4608 [14JY] (see H.R. 2529), H5085 [14JY]

Pharmaceuticals: allow importation of prescription drugs (see S. 319), S642 [10FE]

———clarify the orphan drug exception to the annual fee on branded prescription pharmaceutical manufacturers and importers (see S. 1423), S4960 [27JY] (see H.R. 2672), H5660 [27JY]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (see S. 1211), S3813 [15JN] (see H.R. 965), H1664 [9MR]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (see S. 27), S122 [25JA]

———prohibit marketing of authorized generic drugs (see S. 373), S792 [16FE] (see H.R. 741), H1039 (see H.R. 741), H1070 [16FE]

———provide incentives for investment in research and development for new medicines and enhance access to new medicines (see S. 1137), S3428 [26MY]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (see H.R. 147), H39 [5JA]

Pharmacies: ensure and foster safety and quality of care and competitive marketplace by exempting independent pharmacies from antitrust laws in negotiations with health and health insurance providers (see H.R. 1946), H3342 [23MY]

Public welfare programs: require States to implement a drug testing program for and recipients of assistance under the Temporary Assistance for Needy Families Program (see S. 83), S124 [25JA] (see H.R. 3722), H9926 [16DE]

———require States to implement drug testing program for applicants and recipients of assistance under the Temporary Assistance for Needy Families Program (see H.R. 1769), H3108 [5MY] (see H.R. 3193), H6920 [13OC]

Red Ribbon Week: support goals and ideals (see S. Res. 300), S6764 [19OC] (see H. Res. 427), H6672 [6OC]

Safety: improve (see H.R. 1483), H2603 [12AP] (see H.R. 3026), H6413 [22SE]

———provide for the disposal of drugs pursuant to national pharmaceutical stewardship programs (see H.R. 2939), H6230 [15SE]

Small business: ensure State-certified medical marijuana businesses have full access to banking services (see H.R. 1984), H3644 (see H.R. 1984), H3682 [25MY]

Sports: prohibit the use of performance-enhancing drugs in horseracing (see S. 886), S2687 [4MY] (see H.R. 1733), H3061 [4MY]

Students Against Destructive Decisions (SADD), Inc.: anniversary (see H. Res. 476), H7928 [29NO]

Supreme Court: disapprove Sorrell v. IMS Health Inc., decision on disclosure and use of individual physician prescribing practices (see H. Res. 343), H4793 [8JY]

Taxation: allow a deduction for amounts paid for health insurance and prescription drug costs of individuals (see H.R. 171), H39 [5JA]

———allow a deduction for expenses in connection with the trade or business of selling medical marijuana in accordance with State laws (see H.R. 1985), H3644 (see H.R. 1985), H3682 [25MY]

———deny any deduction for direct-to-consumer advertisements of prescription drugs (see H.R. 722), H922 [15FE]

Unemployment: prevent the payment of unemployment compensation to indviduals discharged for drug or alcohol use (see H.R. 2001), H3753 [26MY]

———require drug testing as a condition for application and receipt of unemployment compensation (see H.R. 3615), H8318 [8DE]

———require substance abuse risk assessment and targeted drug testing as a condition for receipt of unemployment compensation (see H.R. 3601), H8261 [7DE]

Veterans: authorize veterans' treatment courts and encourage services for veterans through drug courts (see H.R. 3721), H9926 [16DE]

———establish veterans' treatment courts (see H.R. 2026), H3754 [26MY]

Letters

Birth Defects Prevention, Risk Reduction, and Awareness Act: Cindy Brownstein, Spina Bifida Association, E979 [27MY]

———Dennis K. Ledford, American Academy of Allergy, Asthma, & Immunology, E979 [27MY]

———Lori Wolf, Organization of Teratology Information Specialists, E980 [27MY]

———Marina L. Weiss, March of Dimes Foundation, E980 [27MY]

———Matthew E. Melmed, ZERO TO THREE—National Center for Infants, Toddlers, and Families, E980 [27MY]

———O. Marion Burton, American Academy of Pediatrics, E980 [27MY]

———Richard N. Waldman, American Congress of Obstetricians and Gynecologists, E980 [27MY]

Deploy National Guard to assist U.S.-Mexico border control activities: Representative Burton, H236 [18JA]

———several Representatives, H235 [18JA]

Drug Trafficking Safe Harbor Elimination Act: Representative Lamar Smith, Committee on the Judiciary (House), H8832 [13DE]

———Representative Upton, Committee on Energy and Commerce (House), H8832 [13DE]

Generating Antibiotic Incentives Now (GAIN) Act: B. Keith English, University of Tennessee Health Science Center and Le Bonheur Children's Hospital, S7029 [2NO]

———Meri Armour, Le Bonheur Children's Hospital, S7029 [2NO]

———several East Tennessee State University administrators and faculty, S7029 [2NO]

———William E. Evans, St. Jude Children's Research Hospital, S7028 [2NO]

National Criminal Justice Commission: Scott Burns, National District Attorneys Association, S6798 [20OC]

———William J. Johnson, National Association of Police Organizations, Inc., S6798 [20OC]

Synthetic Drug Control Act: Jan Rozga, E2216 [8DE]

———Ronald Weich, Dept. of Justice, H8239 [7DE]

Whistleblower allegations relative to Dept. of Justice operations transferring firearms to drug cartels where U.S. law enforcement personnel do not monitor such firearms: Senator Grassley, Committee on the Judiciary (Senate), S2475 [14AP]

Lists

El Paso, TX, student participants in Red Ribbon Poster Contest, E1953 [27OC]

Memorandums

Congressional Investigation Regarding Whistleblower Allegations Relative to Operations Transferring Firearms to Drug Cartels Where U.S. Law Enforcement Personnel Do Not Monitor Such Firearms: Gary M. Styers, Dept. of Justice, S8572 [14DE]

Messages

National Emergency Relative to Narcotics Traffickers in Colombia: President Obama, S6763 [19OC], H6986 [21OC]

Remarks in House

Aviation: include ultralight aircraft under the definition of aircraft relative to aviation smuggling and identify equipment and technology to track illegal use of such aircraft near the Mexican border (S. 1974), H8981 [15DE]

Baron, Mel: American Pharmacists Association Foundation Pinnacle Award recipient, E1175 [23JN]

Border Patrol: removal of U.S.-Mexico border drug and people smugglers lookout posts funding, H3856 [1JN]

Centers for Disease Control and Prevention: establish and implement a birth defects prevention, risk reduction, and public awareness program (H.R. 2029), E979 [27MY]

Chaudhuri, Bodhisattwa: Pharmaceutical Research and Manufacturers of America Foundation award recipient, E1445 [29JY]

Cogswell Hall, Inc.: tribute, E1644 [15SE]

Contraceptives: establish certain duties for pharmacies to ensure provision of FDA-approved contraception (H.R. 2659), E1411 [26JY]

Controlled Substances Act: exclude industrial hemp from the definition of marijuana, E793 [3MY]

———exclude industrial hemp from the definition of marijuana (H.R. 1831), E869 [11MY]

———place synthetic drugs in Schedule I indicating high potential for abuse, no current accepted medical use, and lack of accepted safety for use under medical supervision (H.R. 1254), H8238-H8244 [7DE], E2216, E2219 [8DE], E2224, E2226 [12DE], E2240 [13DE], E2270 [15DE], E2291 [16DE]

Crime: clarify that persons who conspire or engage in conduct within the U.S. to possess, traffic, or abet traffickers of illegal drugs outside the U.S., may be criminally prosecuted in the U.S. (H.R. 313), H8831-H8834 [13DE]

———decriminalization of marijuana, H4373 [22JN], H4468 [23JN]

———increase penalties for operators of pill mills (H.R. 1065), H2298 [5AP]

Dept. of HHS: AIDS Drug Assistance Program funding, H1185, H1186 [17FE]

———amend and reauthorize the controlled substance monitoring program (H.R. 866), E385 [1MR]

———proposal to require all health plans to cover certain birth control procedures and drugs, H7382 [4NO]

Dept. of Homeland Security: implement a comprehensive border security plan to combat illegal immigration, drug and alien smuggling, and violent activity along the southwest border of the U.S., H3097-H3102 [5MY]

———Shadow Wolves border patrol program funding, H3858 [1JN]

Dept. of Justice: appoint special counsel to investigate whistleblower allegations relative to operations transferring firearms to drug cartels where U.S. law enforcement personnel do not monitor such firearms, H6677 [11OC], H7237 [2NO], H8265 [8DE], H8973 [15DE]

———National Drug Intelligence Center funding, H886, H887 [15FE], H3247 [12MY]

———repeal establishment of National Drug Intelligence Center, H3638, H3639 [25MY]

———whistleblower allegations relative to operations transferring firearms to drug cartels where U.S. law enforcement personnel do not monitor such firearms, H3163 [11MY], H5090 [15JY], H5167 [19JY], H6846 [12OC], H8345-H8347 [12DE]

Dept. of Veterans Affairs: provide for certain requirements relative to immunization of veterans (H.R. 1930), E896 [13MY]

Diaz, Jesus E., Jr.: arrest for detainment of drug smuggler along the Mexican border, H7114 [26OC], H7214 [2NO]

Diseases: global fight against malaria, E2197 [7DE]

———reduce disparities and improve access to diagnosis and treatment of prostate cancer for underserved populations and men with a family history of prostate cancer (H.R. 2159), E1082 [14JN]

Drug abuse: national drug control policy, H4190 [15JN]

Drug Take-Back Day: observance, H7988 [30NO]

FDA: funding, H824 [15FE], E1123 [16JN]

———prohibit funding for distribution of mifepristone (RU-486) through telemedicine, H4268, H4269 [15JN], H4319 [16JN]

———require use of hard science in developing regulations, H4236-H4238 [15JN]

Federal agencies and departments: ensure agency rule reform does not create regulatory burdens for providing low-cost prescription drugs for seniors, veterans, servicemen, and their families, H8103 [2DE]

Health: impact of substance abuse and addiction, E501 [16MR]

———increase awareness relative to potential risks associated with the use of anti-coagulant drugs to treat blood clots and deep vein thrombosis (DVT), E530 [17MR]

———support regenerative medicine through research funding and commercial development of regenerative products and develop a regulatory environment that enables rapid approval of safe and effective products, H638 [10FE]

Holder, Attorney General: call for resignation due to contradictory testimony during investigation into whistleblower allegations relative to operations transferring firearms to drug cartels, H8191 [7DE]

Intelligence services: prioritize funding to counter transnational drug trafficking and drug-related crime at U.S. borders, H6033, H6034 [9SE]

John 3-16 Ministries, Inc.: tribute, H6866 [13OC]

Law enforcement: coordinate efforts to protect U.S. border cities from drug trafficking, gunrunning, illegal alien smuggling, violence, and kidnapping along and across U.S. borders, H6843-H6848 [12OC]

———limit application of Federal laws to the distribution and consumption of marijuana (H.R. 2306), H4474 [23JN]

Medicaid: require drug manufacturers to pay rebates to State prescription drug discount programs as a condition of participation in a rebate agreement for outpatient prescription drugs (H.R. 989), E441 [9MR]

Medicare: authorize the Dept. of HHS to negotiate lower covered part D prescription drug prices for beneficiaries, H5289 [21JY]

———eliminate gap in coverage of prescription drug benefit, H100 [6JA], H2509 [7AP], H2827 [14AP], H3272 [12MY]

———improve access to physical medicine and rehabilitation services (H.R. 2785), E1470 [1AU]

———provide coverage for the shingles vaccine (H.R. 859), E387 [1MR]

———provide for coverage of home infusion drug therapy (H.R. 2195), H4200 [15JN]

Mexico: assist in fighting drug cartels and curbing violence against Mexican and U.S. citizens, H1428 [1MR], H5402 [25JY]

———call for investigation of murder of David Hartley on Falcon Lake on U.S.-Mexico border, H6568 [5OC]

National security: deploy National Guard to assist U.S.-Mexico border control activities, H73 [6JA], H106 [7JA], H235 [18JA], H259 [19JA], H1074, H1093 [17FE], H1399 [1MR], H8012 [1DE]

———deploy National Guard to assist U.S.-Mexico border control activities (H.R. 152), H797 [15FE], H2319 [5AP], H6844, H6845 [12OC]

———ensure that legislative language addressing border security improvement differentiates between high-risk and low-risk borders, E1680 [21SE]

———improve border security, H2315-H2320 [5AP], H3284, H3297 [13MY], H3765 [31MY], H6848 [12OC], H6858 [13OC], H7901 [29NO]

———improve border security (H.R. 1299), E1680 [21SE]

———maintain National Guard assistance in U.S.-Mexico border control activities, H1896 [16MR], H3638 [25MY]

Office of the Director of National Intelligence: require threat assessment of foreign drug traffickers using Federal lands for drug operations, H6016 [9SE], H9808 [16DE]

Patient Protection and Affordable Care Act: impact of repeal on senior citizen prescription drug rebates, H270, H271 [19JA], H8201 [7DE]

———impact of repeal on senior citizens, H87 [6JA]

———repeal certain limitations on contributions to flexible spending accounts and on purchase of over the counter medications, H529 [8FE]

Pediatric Interim Care Center: anniversary, E772 [2MY]

Pharmaceuticals: preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (H.R. 965), E437 [9MR]

———provide tax credit to retirement age individuals, remove barriers to importation, and prohibit certain regulation of Internet sites relative to prescription drugs (H.R. 147), E7 [5JA]

———recognize importance and value of pharmacists, E428 [8MR]

Public welfare programs: require States to implement drug testing program for applicants and recipients of assistance under the Temporary Assistance for Needy Families Program (H.R. 3193), E1864 [13OC]

Puerto Rico: establish a Caribbean border initiative to combat drug trafficking and violence, H8733 [13DE]

Red Ribbon Week: support goals and ideals, E1937 [26OC], E1953 [27OC]

Rio Grande Safe Communities Coalition: anniversary, E756 [15AP]

Safety: provide for the disposal of drugs pursuant to national pharmaceutical stewardship programs (H.R. 2939), E1639 [15SE]

Santa Barbara County, CA: tribute to opening of veterans treatment court, H7732 [17NO]

Taxation: allow a deduction for expenses in connection with the trade or business of selling medical marijuana in accordance with State laws (H.R. 1985), E953 [25MY]

———make taxes on marijuana and hemp, in States where such products are legal, comparable to taxes on alcohol and tobacco, H4957 [13JY]

Troy, MI: anniversary of Troy Community Coalition, E1957 [27OC]

Unemployment: require drug testing as a condition for application and receipt of unemployment compensation, H8803, H8804, H8815-H8817 [13DE], H9975 [20DE], E2342 [23DE]

———require substance abuse risk assessment and targeted drug testing as a condition for receipt of unemployment compensation (H.R. 3601), E2261 [14DE]

Veterans: provide pathways back to work for those looking for jobs and mental health services and substance abuse treatments, H7222 [2NO]

Remarks in Senate

Alaska: history of Iditarod dogsled race relative to transporting diphtheria serum to Nome, AK, S1814 [17MR]

Aviation: include ultralight aircraft under the definition of aircraft relative to aviation smuggling and identify equipment and technology to track illegal use of such aircraft near the Mexican border, S7791 [18NO]

———include ultralight aircraft under the definition of aircraft relative to aviation smuggling and identify equipment and technology to track illegal use of such aircraft near the Mexican border (S. 1485), S5260 [2AU]

———include ultralight aircraft under the definition of aircraft relative to aviation smuggling and identify equipment and technology to track illegal use of such aircraft near the Mexican border (S. 1974), S8466 [8DE]

Breuer, Lanny: call for resignation for allegations relative to operations transferring firearms to drug cartels where U.S. law enforcement personnel do not monitor such firearms, S8390-S8392 [7DE]

Controlled Substances Act: place synthetic drugs in Schedule I indicating high potential for abuse, no current accepted medical use, and lack of accepted safety for use under medical supervision (S. 605), S1830 [17MR]

Corvallis, OR: tribute to Benton County, OR, Drug Treatment Court, S8065 [30NO]

Crime: address issues relative to prescription drug abuse, S6591 [17OC]

———enhance penalties for marketing controlled substances to minors (S. 513), S1410, S1411 [8MR]

———increase penalties for counterfeit drug trafficking (S. 1886), S7705 [17NO]

———increase penalties for stealing, transporting, and storing stolen prescription drugs (S. 1002), S6592 [17OC]

DEA: authorize certain health care professionals in nursing homes to transmit DEA-licensed practitioners' orders to deliver pain medications (S. 1560), S5627 [14SE]

Dept. of Defense: authorize a pilot program on enhancements of efforts on mental health in the National Guard and Reserves through community partnerships (S. 1465), S5194 [1AU]

Dept. of Education: authorize grant programs to ensure successful, safe, and healthy students by promoting wellness, preventing bullying, violence, and drug use, and fostering a positive school climate (S. 919), S2793 [9MY]

Dept. of HHS: reauthorize grants to assist children affected by methamphetamine or other substance abuse under the Promoting Safe and Stable Families program (S. 1234), S3930 [20JN]

Dept. of Homeland Security: reduce trafficking of drugs and prevent human smuggling across the Southwest border by deterring construction and use of border tunnels (S. 1236), S3931 [20JN]

Dept. of Justice: establish the Alaska Safe Families and Villages Demonstration Project (S. 1192), S3773 [14JN]

———prohibit funding for operations transferring firearms to drug cartels where U.S. law enforcement personnel do not monitor such firearms, S6634, S6635, S6648 [18OC]

———provide with additional tools to target extraterritorial drug trafficking activity (S. 1612), S5908 [22SE], S8690 [15DE]

———response to request for release of documents on whistleblower allegations relative to operations transferring firearms to drug cartels where U.S. law enforcement personnel do not monitor such firearms, S2765, S2770 [9MY], S4139 [28JN]

———whistleblower allegations relative to operations transferring firearms to drug cartels where U.S. law enforcement personnel do not monitor such firearms, S2474 [14AP], S6991-S6993 [1NO], S8110 [1DE], S8570-S8573 [14DE]

District of Columbia: prohibit funding for needle exchange programs, S8694 [16DE]

Economy: national objectives priority assignments, S7988 [29NO]

FDA: ensure valid generic drugs may enter the market (S. 1882), S7616 [16NO]

———establish a nanotechnology regulatory science program (S. 1662), S6332 [6OC]

———improve capacity to prevent drug shortages (S. 296), S6901 [31OC]

———improve the safety of Internet pharmacies (S. 2002), S8684 [15DE]

———prohibit funding to prevent individuals from importing prescription drugs from Canada for personal use, S6650 [18OC], S6730, S6749 [19OC], S6794, S6797, S6801 [20OC]

———provide incentives for the development of qualified infectious disease products (H.R. 2182), S7028-S7030 [2NO]

Government regulations: ban the sale of certain synthetic drugs (S. 839), S2520 [14AP]

———increase Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths (S. 507), S1408 [8MR]

Health: prohibit funding to implement regulations regarding the removal of essential-use designation for epinephrine used in oral pressurized metered-dose inhalers, S6934 [1NO]

Hereditary Angioedema Awareness Day: observance (S. Res. 286), S6226 [5OC]

Medicare: deliver a meaningful drug benefit and lower prescription drug prices (S. 560), S1561 [10MR]

———exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals (S. 733), S2139 [5AP]

———expand access to medication therapy management services (S. 274), S546 [3FE]

———extended coverage of immunosuppressive drugs for kidney transplant patients and other renal dialysis provisions (S. 1454), S5076 [29JY]

———provide for coverage of home infusion drug therapy (S. 1203), S3831 [15JN]

———require drug manufacturers to provide rebates for drugs dispensed to low-income individuals under the prescription drug benefit program (S. 1206), S3836 [15JN]

———require the Dept. of HHS to negotiate lower covered part D prescription drug prices for beneficiaries (S. 44), S2369 [12AP]

———study issues on access to intravenous immune globulin (IVIG) for beneficiaries in all care settings and establish demonstration project on benefits of coverage to administer IVIG in the home (S. 960), S2933 [12MY]

Medicare/Medicaid: prevent misuse, overutilization, and trafficking of prescription drugs by limiting access to such drugs by high-risk beneficiaries (S. 882), S6592 [17OC]

National Association of Chain Drug Stores: observance of RxIMPACT Day, S1399 [8MR]

National Criminal Justice Commission: establish, S6573 [17OC], S6794, S6796-S6800, S6802, S6851 [20OC], S6983 [1NO]

National Medicine Abuse Awareness Month: designate (S. Res. 261), S5581 [13SE], S5933 [23SE]

Patient Protection and Affordable Care Act: repeal prohibition on using medical savings account funds to purchase over-the-counter medications (S. 1368), S4609 [14JY]

Pharmaceuticals: allow importation of prescription drugs (S. 319), S644 [10FE]

———cost regulation of drug hormone, progesterone, to prevent premature births, S2800 [9MY]

———preserve effectiveness of medically important antibiotics used in treatment of human and animal diseases (S. 1211), S3837-S3839 [15JN]

———prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (S. 27), S143 [25JA]

———prohibit marketing of authorized generic drugs, S1098 [2MR]

———prohibit marketing of authorized generic drugs (S. 373), S797 [16FE]

Red Ribbon Week: support goals and ideals (S. Res. 300), S6787, S6788 [19OC]

Senate Caucus on International Narcotics Control: release of ``Responding to Violence in Central America'' report, S5895 [22SE]

Sports: prohibit the use of performance-enhancing drugs in horseracing (S. 886), S2689 [4MY]

Supreme Court: hearing of arguments in U.S. v. Jones relative to law enforcement use of global positioning system (GPS) surveillance without a warrant, S7174 [8NO]

Tapp, David A.: National Association of Drug Court Professionals All Rise Leadership Award recipient, S6657 [18OC]

U.S. Sentencing Commission: vote on applying retroactively the sentencing guideline amendment on sentence disparities between powder and crack cocaine offenses, S4209 [29JN]

Reports filed

Border Enforcement Security Task Force Act: Committee on Homeland Security (House) (H.R. 915) (H. Rept. 112-268), H7396 [4NO]

Border Tunnel Prevention Act: Committee on the Judiciary (Senate) (S. 1236), S8679 [15DE]

Combating Dangerous Synthetic Stimulants Act: Committee on the Judiciary (Senate) (S. 409), S5017 [28JY]

Combating Designer Drugs Act: Committee on the Judiciary (Senate) (S. 839), S5017 [28JY]

Counterfeit Drug Penalty Enhancement Act: Committee on the Judiciary (Senate) (S. 1886), S8460 [8DE]

Dangerous Synthetic Drug Control Act: Committee on the Judiciary (Senate) (S. 605), S5071 [29JY]

Drug Trafficking Safe Harbor Elimination Act: Committee on the Judiciary (House) (H.R. 313) (H. Rept. 112-324), H8727 [12DE]

Preserve Access to Affordable Generics Act: Committee on the Judiciary (Senate) (S. 27), S4845 [22JY]

Secure Border Act: Committee on Homeland Security (House) (H.R. 1299) (H. Rept. 112-274), H7405 [10NO]

Synthetic Drug Control Act: Committee on Energy and Commerce (House) (H.R. 1254) (H. Rept. 112-295), H7898 [22NO]

———Committee on the Judiciary (House) (H.R. 1254) (H. Rept. 112-295), H7898 [22NO]

Texts of

H.R. 313, Drug Trafficking Safe Harbor Elimination Act, H8831 [13DE]

H.R. 1254, Synthetic Drug Control Act, H8238 [7DE]

S. 8, Tough and Smart National Security Act, S129 [25JA]

S. 27, Preserve Access to Affordable Generics Act, S144-S146 [25JA]

S. 31, Prescription Drug and Health Improvement Act, S151 [25JA]

S. 513, Saving Kids From Dangerous Drugs Act, S1411 [8MR]

S. 560, Medicare Prescription Drug Savings and Choice Act, S1561-S1563 [10MR]

S. 733, exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals, S2140 [5AP]

S. 886, Interstate Horseracing Improvement Act, S2690 [4MY]

S. 919, Successful, Safe, and Healthy Students Act, S2794-S2797 [9MY]

S. 1192, Alaska Safe Families and Villages Act, S3774-S3776 [14JN]

S. 1211, Preservation of Antibiotics for Medical Treatment Act, S3839-S3841 [15JN]

S. 1236, Border Tunnel Prevention Act, S3932 [20JN]

S. 1454, extended Medicare coverage of immunosuppressive drugs for kidney transplant patients and other renal dialysis provisions, S5076 [29JY]

S. 1465, Joining Forces for Military Mental Health Act, S5194 [1AU]

S. 1485, Ultralight Aircraft Smuggling Prevention Act, S5260 [2AU]

S. 1612, Targeting Transnational Drug Trafficking Act, S5908 [22SE], S8690 [15DE]

S. 1662, Nanotechnology Regulatory Science Act, S6333 [6OC]

S. 1882, Fair and Immediate Release of Generic Drugs (FAIR Generics) Act, S7616 [16NO]

S. 1884, School Access to Emergency Epinephrine Act, S7704 [17NO]

S. 1886, Counterfeit Drug Penalty Enhancement Act, S7705 [17NO]

S. 1974, Ultralight Aircraft Smuggling Prevention Act, S8466 [8DE]

S. 2002, Online Pharmacy Safety Act, S8685-S8687 [15DE]

S. Res. 47, recognize importance of biosecurity and agrodefense, S646 [10FE]

S. Res. 261, National Medicine Abuse Awareness Month, S5581 [13SE], S5933 [23SE]

S. Res. 286, Hereditary Angioedema Awareness Day, S6225 [5OC]

S. Res. 300, support goals and ideals of Red Ribbon Week, S6769, S6788 [19OC]